Journal of Head & Neck Physicians and Surgeons · Published 2025-01-01 · Journal article · DOI 10.4103/jhnps.jhnps_54_25
Background: The treatment of head and neck tumors is very complex due to the diversity of the diseases and the proximity of many malignancies to vital organs such as blood vessels. Objective: This study aims to investigate patients with head and neck cancers referred to radiotherapy in Sabzevar, Iran, in 2024. Materials and Methods: This cross-sectional study reviewed the records of 97 head and neck cancer patients in Sabzevar in Iran. The patients’ records were analyzed for clinicopathological factors and treatments performed, including chemotherapy, radiotherapy, and surgery; ultimately, survival data were examined. Results: Statistical analysis shows that 60.8% (59 patients) were male and 39.2% (38 patients) were female, indicating a lower prevalence of head and neck cancers in women than in men. In terms of treatment, the most common therapeutic approaches were chemoradiotherapy (57.7%), radiotherapy (16.5%), and chemoradiotherapy + surgery (12.4%). The overall mean survival of patients was 34 ± 19 months with a median of 6 months. Survival analysis indicated that squamous cell carcinoma patients over the age of 65 years had a higher mortality rate. Conclusions: There is a pressing need for early detection of the disease in younger individuals and its early stages through an organized screening program and regular checkups for at-risk individuals.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →